← 產業報告目錄

Intensive Care Unit Market Research Report by Product Type (Pulse Oximeter, Sphygmomanometer, Beds, Ventilators, Oxygen Concentrators, Resuscitators, Patients Monitors, Infusion Systems, Others), by Application (Cardiovascular Disease, Oncology, Respiratory, Neurology, Others), by End User (Hospital, Specialty Clinics), and by Region (North America, Europe , Asia-Pacific, South America, MEA) Forecast till 2035

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2026-03-26頁數 215報告編號 MRFRHC19770CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

The Global Intensive Care Unit (ICU) Market is projected to reach USD 12,689.8 million by 2035, expanding at a CAGR of 4.7% from 2025 to 2035. This steady growth reflects rising demand for advanced critical care infrastructure and services worldwide. Escalating Burden of Non-Communicable Diseases (NCDs) The‍‌‍‍‌ increasing occurrence of chronic diseases such as cardiovascular diseases, cancer, respiratory disorders, and diabetes, that account for almost three-quarters of deaths worldwide, is a major factor behind the continued ICU admissions for acute complications. This trend is making the patients even more dependent on intensive care requiring an advanced infrastructure for intensive care around the world. Segment-Wise Snapshot of ICU Market By Product Type: • Pulse Oximeter – Continuous oxygen saturation monitoring in ICU • Sphygmomanometer – Accurate blood pressure measurement in critical care • Beds – Adjustable ICU beds for patient support and care • Ventilators – Life-support systems for severe respiratory failure • Oxygen Concentrators – Reliable oxygen supply for critical patients • Resuscitators – Emergency devices for immediate patient revival • Patient Monitors – Real-time tracking of vital health parameters • Infusion Systems – Controlled delivery of fluids and medications • Others – Auxiliary devices supporting ICU treatment processes By Application: • Cardiovascular Disease – Intensive care for cardiac emergencies • Oncology – Critical support for cancer-related complications • Respiratory – Management of severe respiratory disorders • Neurology – ICU care for stroke and brain injuries • Others – Treatment of diverse critical health conditions By End User: • Hospital – Primary centers for advanced ICU treatment • Specialty Clinics – Focused care for specific critical conditions Global ICU Market Regional Snapshot Advanced ICU infrastructure is available in North America and Europe that are however facing capacity issues and regional disparities. Rapidly growing expansion of ICU infrastructure has been witnessed in Asia Pacific whereas South America and MEA continue to suffer from the issues of uneven access and infrastructure. Strategic Partnerships Enhancing Monitoring Capabilities Koninklijke Philips N.V., through its new strategic collaborations aimed at advancing patient-monitoring technologies and expanding clinical capabilities, is continuously enhancing its ICU portfolio. The new and additional multi-year Medtronic collaboration was geared at integrating advanced sensor solutions into Philips' systems while reducing procurement procedures and improving access to critical monitoring tools across hospitals. Digital Transformation Driving ICU Efficiency Hospitals are now able to cover ICU more effectively, optimize resource usage, and cope with geographically dispersed patients through tele-critical care solutions. By improving operational scalability and care delivery, this digital transformation is offering a strong strategic ‍‌‍‍‌advantage. Key Report Attributes • Market Size 2035: USD 12,689.8 Million • CAGR (2025-2035): 4.7% • Base Year: 2024 • Market Forecast Period: 2025-2035 Industry Segmentations Growth • By Product Type: Pulse Oximeter - 6.8%, Sphygmomanometer - 9.3%. • By Application: Cardiovascular Disease - 3.5%, Oncology - 5.5% • By End User: Hospital - 4.4%, Specialty Clinics - 5.9%.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............ 19 2 MARKET INTRODUCTION ......... 21 2.1 DEFINITION ......... 21 2.2 SCOPE OF THE STUDY ....... 21 2.3 RESEARCH OBJECTIVE .............. 21 2.4 MARKET STRUCTURE ....... 22 3 RESEARCH METHODOLOGY ............ 23 3.1 OVERVIEW ........... 23 3.2 DATA FLOW ......... 25 3.2.1 DATA MINING PROCESS ......... 25 3.3 PURCHASED DATABASE: ........... 26 3.4 SECONDARY SOURCES: .............. 27 3.4.1 SECONDARY RESEARCH DATA FLOW: ............ 28 3.5 PRIMARY RESEARCH: ........ 29 3.5.1 PRIMARY RESEARCH DATA FLOW: ........... 30 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ....... 31 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE .......... 31 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......... 32 3.6.1 CONSUMPTION & NET TRADE APPROACH ............. 32 3.6.2 REVENUE ANALYSIS APPROACH ....... 32 3.7 DATA FORECASTING.......... 33 3.7.1 DATA FORECASTING TECHNIQUE ....... 33 3.8 DATA MODELING ........ 34 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........... 34 3.8.2 DATA MODELING: ........ 35 3.9 TEAMS AND ANALYST CONTRIBUTION ........ 37 4 MARKET DYNAMICS ........ 39 4.1 INTRODUCTION ........... 39 4.2 MARKET TRENDS AND GROWTH AFFECTING FACTORS ............ 40 4.3 GROWTH PARAMETERS MAPPED - DRIVERS ....... 40 4.3.1 RAPID POPULATION AGEING AND GROWTH OF HIGH-RISK COHORTS ....... 40 4.3.2 RISING BURDEN OF NCDS AND ACUTE COMPLICATIONS ............ 41 4.3.3 EXPANSION OF SURGICAL, EMERGENCY, AND TRAUMA CARE REQUIRING ICU SUPPORT ......... 42 4.3.4 RISING HEALTH EXPENDITURE AND POLICY FOCUS ON EMERGENCY & CRITICAL CARE ............ 43 4.3.5 HEALTH SECURITY IMPERATIVES AND PANDEMIC PREPAREDNESS POST COVID-19 ....... 43 4.4 GROWTH INHIBITORS MAPPED - RESTRAINTS ............ 45 4.4.1 CRITICAL-CARE WORKFORCE SHORTAGES AND BURNOUT ...... 45 4.4.2 HIGH-COST INTENSITY OF ICU CARE AND BUDGET PRESSURES ........... 46 4.4.3 STRUCTURAL INFRASTRUCTURE AND ACCESS GAPS, ESPECIALLY IN LMICS ......... 46 4.5 MARKET OPPORTUNITIES MAPPED ....... 48 4.5.1 SCALING TELE-ICU, INTEROPERABLE MONITORING, AND AI-ENABLED DECISION SUPPORT ....... 48 4.5.2 INFECTION-PREVENTION AND AMR-FOCUSED ICU SOLUTIONS...... 48 4.5.3 AFFORDABLE CRITICAL-CARE MODELS FOR LMICS BACKED BY GLOBAL FINANCING ....... 49 4.6 IMPACT ANALYSIS OF COVID – 19 ........... 50 4.6.1 IMPACT ON OVERALL F&B MARKET ............. 51 4.6.2 IMPACT ON GLOBAL INTENSIVE CARE UNIT (ICU) MARKET .......... 53 4.6.3 IMPACT ON SUPPLY CHAIN OF INTENSIVE CARE UNIT (ICU) MARKET .............. 54 4.6.4 IMPACT ON MARKET DEMAND OF INTENSIVE CARE UNIT (ICU) MARKET .......... 56 4.6.5 IMPACT ON PRICING OF INTENSIVE CARE UNIT (ICU) MARKET .............. 57 5 MARKET FACTOR ANALYSIS ............ 59 5.1 REGULATORY ENVIRONMENT & COMPLIANCE ............ 59 5.2 TECHNOLOGICAL TRENDS & INNOVATION ............ 60 5.3 MARKET ENTRY & EXIT BARRIERS ........ 63 5.4 PARTNERSHIPS & COLLABORATIONS ............. 64 5.5 CONSUMER & HEALTHCARE PROVIDER PREFERENCES .............. 67 5.6 PESTLE ANALYSIS .............. 69 5.6.1 POLITICAL FACTORS ...... 69 5.6.2 ECONOMIC FACTORS ............. 69 5.6.3 SOCIAL FACTORS ......... 69 5.6.4 TECHNOLOGICAL FACTORS ...... 70 5.6.5 LEGAL FACTORS .......... 70 5.6.6 ENVIRONMENTAL FACTORS ...... 70 5.7 PORTER’S FIVE FORCES MODEL ...... 71 5.7.1 BARGAINING POWER OF SUPPLIERS ............. 71 5.7.2 BARGAINING POWER OF BUYERS ....... 72 5.7.3 THREAT OF NEW ENTRANTS .............. 72 5.7.4 THREAT OF SUBSTITUTES ........ 73 5.7.5 INTENSITY OF RIVALRY ............ 73 5.8 INVESTMENT & FUNDING SCENARIOS ........... 73 6 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE .......... 77 6.1 INTRODUCTION ........... 77 6.2 PULSE OXIMETER ...... 79 6.3 SPHYGMOMANOMETER ............ 81 6.4 BEDS .............. 82 6.5 VENTILATORS ............. 84 6.6 OXYGEN CONCENTRATORS .............. 86 6.7 RESUSCITATORS ........ 88 6.8 PATIENTS MONITORS ....... 90 6.9 INFUSION SYSTEMS ........... 92 6.10 OTHERS ........ 94 7 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION .............. 97 7.1 INTRODUCTION ........... 97 7.2 CARDIOVASCULAR DISEASE ............. 99 7.3 ONCOLOGY ........... 101 7.4 RESPIRATORY ............. 103 7.5 NEUROLOGY ........ 105 7.6 OTHERS ........ 106 8 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER .......... 109 8.1 INTRODUCTION ........... 109 8.2 HOSPITAL ............. 110 8.3 SPECIALTY CLINICS ........... 113 9 GLOBAL INTENSIVE CARE UNIT MARKET, BY REGION .............. 115 9.1 OVERVIEW ........... 115 9.2 NORTH AMERICA ....... 116 9.2.1 U.S........ 120 9.2.2 CANADA .......... 122 9.3 EUROPE ........ 123 9.3.1 GERMANY ........ 127 9.3.2 UK ........ 128 9.3.3 FRANCE ........... 130 9.3.4 RUSSIA ............ 131 9.3.5 ITALY ...... 132 9.3.6 SPAIN ............. 134 9.3.7 REST OF EUROPE ......... 135 9.4 ASIA-PACIFIC ...... 137 9.4.1 CHINA ............. 141 9.4.2 INDIA .............. 142 9.4.3 JAPAN ............ 144 9.4.4 SOUTH KOREA ............ 145 9.4.5 MALAYSIA ........ 146 9.4.6 THAILAND ......... 148 9.4.7 INDONESIA ....... 149 9.4.8 REST OF ASIA PACIFIC .......... 150 9.5 SOUTH AMERICA ....... 152 9.5.1 BRAZIL ............. 156 9.5.2 MEXICO ........... 157 9.5.3 ARGENTINA ....... 159 9.5.4 REST OF SOUTH AMERICA ...... 160 9.6 MIDDLE EAST & AFRICA ............ 162 9.6.1 GCC COUNTRIES .......... 166 9.6.2 SOUTH AFRICA ............. 168 9.6.3 REST OF MEA ............ 169 10 COMPETITIVE LANDSCAPE .............. 172 10.1 INTRODUCTION ........... 172 10.2 COMPETITION DASHBOARD .............. 173 10.2.1 PRODUCT PORTFOLIO ...... 174 10.2.2 REGIONAL PRESENCE ....... 174 10.2.3 STRATEGIC ALLIANCES ............. 174 10.2.4 INDUSTRY EXPERIENCES ........... 174 10.3 MARKET SHARE ANALYSIS, 2024 ........... 174 10.4 WHO ARE THE MAJOR DISRUPTORS & INNOVATORS ......... 175 10.5 WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS ........... 176 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ........... 177 10.6.1 PRODUCT LAUNCH ........... 177 10.6.2 AGREEMENT AND PARTNERSHIP ........ 177 10.6.3 OTHER ............. 178 11 COMPANY PROFILES ...... 179 11.1 KONINKLIJKE PHILIPS N.V. .............. 179 11.1.1 COMPANY OVERVIEW ....... 179 11.1.2 FINANCIAL OVERVIEW ...... 180 11.1.3 PRODUCTS OFFERED......... 181 11.1.4 KEY DEVELOPMENTS ........ 181 11.1.5 SWOT ANALYSIS .............. 182 11.1.6 KEY STRATEGY ............ 182 11.2 MEDTRONIC ........ 183 11.2.1 COMPANY OVERVIEW ....... 183 11.2.2 FINANCIAL OVERVIEW ...... 184 11.2.3 PRODUCTS OFFERED......... 184 11.2.4 KEY DEVELOPMENTS ........ 185 11.2.5 SWOT ANALYSIS .............. 185 11.2.6 KEY STRATEGY ............ 186 11.3 HAMILTON MEDICAL AG ........... 187 11.3.1 COMPANY OVERVIEW ....... 187 11.3.2 PRODUCTS OFFERED......... 188 11.3.3 SWOT ANALYSIS .............. 188 11.3.4 KEY STRATEGY ............ 188 11.4 GETINGE AB ........ 190 11.4.1 COMPANY OVERVIEW ....... 190 11.4.2 FINANCIAL OVERVIEW ...... 191 11.4.3 PRODUCTS OFFERED......... 191 11.4.4 KEY DEVELOPMENTS ........ 192 11.4.5 SWOT ANALYSIS .............. 192 11.4.6 KEY STRATEGY ............ 193 11.5 GE HEALTHCARE ....... 194 11.5.1 COMPANY OVERVIEW ....... 194 11.5.2 FINANCIAL OVERVIEW ...... 196 11.5.3 PRODUCTS OFFERED......... 196 11.5.4 SWOT ANALYSIS .............. 197 11.5.5 KEY STRATEGY ............ 197 11.6 STRYKER CORPORATION .......... 198 11.6.1 COMPANY OVERVIEW ....... 198 11.6.2 FINANCIAL OVERVIEW ...... 199 11.6.3 PRODUCTS OFFERED......... 199 11.6.4 SWOT ANALYSIS .............. 201 11.6.5 KEY STRATEGY ............ 201 11.7 SHENZHEN MINDRAY BIO‑MEDICAL ELECTRONICS CO., LTD. ............ 202 11.7.1 COMPANY OVERVIEW ....... 202 11.7.2 PRODUCTS OFFERED......... 203 11.7.3 SWOT ANALYSIS .............. 204 11.7.4 KEY STRATEGY ............ 204 11.8 VYAIRE MEDICAL, INC. .............. 205 11.8.1 COMPANY OVERVIEW ....... 205 11.8.2 PRODUCTS OFFERED......... 206 11.8.3 SWOT ANALYSIS .............. 206 11.8.4 KEY STRATEGY ............ 206 11.9 ICU MEDICAL, INC. .............. 207 11.9.1 COMPANY OVERVIEW ....... 207 11.9.2 PRODUCTS OFFERED......... 208 11.9.3 KEY DEVELOPMENTS ........ 208 11.9.4 SWOT ANALYSIS .............. 209 11.9.5 KEY STRATEGY ............ 209 11.10 BAXTER INTERNATIONAL ....... 210 11.10.1 COMPANY OVERVIEW ....... 210 11.10.2 FINANCIAL OVERVIEW ...... 211 11.10.3 PRODUCTS OFFERED......... 212 11.10.4 KEY DEVELOPMENTS ........ 212 11.10.5 SWOT ANALYSIS .............. 212 11.10.6 KEY STRATEGY ............ 213 12 DATA CITATIONS ............. 214
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 35 TABLE 2 KEY PARTNERSHIP TYPES IN THE ICU MARKET 65 TABLE 3 SELECTED GLOBAL ICU-RELEVANT COLLABORATIONS 66 TABLE 4 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION) 78 TABLE 5 GLOBAL INTENSIVE CARE UNIT MARKET, BY PULSE OXIMETER, 2024 & 2035 (USD MILLION) 80 TABLE 6 GLOBAL INTENSIVE CARE UNIT MARKET, BY SPHYGMOMANOMETER, 2024 & 2035 (USD MILLION) 82 TABLE 7 GLOBAL INTENSIVE CARE UNIT MARKET, BY BEDS, 2024 & 2035 (USD MILLION) 84 TABLE 8 GLOBAL INTENSIVE CARE UNIT MARKET, BY VENTILATORS, 2024 & 2035 (USD MILLION) 86 TABLE 9 GLOBAL INTENSIVE CARE UNIT MARKET, BY OXYGEN CONCENTRATORS, 2024 & 2035 (USD MILLION) 88 TABLE 10 GLOBAL INTENSIVE CARE UNIT MARKET, BY RESUSCITATORS, 2024 & 2035 (USD MILLION) 90 TABLE 11 GLOBAL INTENSIVE CARE UNIT MARKET, BY PATIENT MONITORS, 2024 & 2035 (USD MILLION) 92 TABLE 12 GLOBAL INTENSIVE CARE UNIT MARKET, BY INFUSION SYSTEMS, 2024 & 2035 (USD MILLION) 94 TABLE 13 GLOBAL INTENSIVE CARE UNIT MARKET, BY OTHERS, 2024 & 2035 (USD MILLION) 96 TABLE 14 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 98 TABLE 15 GLOBAL INTENSIVE CARE UNIT MARKET, BY CARDIOVASCULAR DISEASE, 2024 & 2035 (USD MILLION) 100 TABLE 16 GLOBAL INTENSIVE CARE UNIT MARKET, BY ONCOLOGY, 2024 & 2035 (USD MILLION) 103 TABLE 17 GLOBAL INTENSIVE CARE UNIT MARKET, BY RESPIRATORY, 2024 & 2035 (USD MILLION) 104 TABLE 18 GLOBAL INTENSIVE CARE UNIT MARKET, BY NEUROLOGY, 2024 & 2035 (USD MILLION) 106 TABLE 19 GLOBAL INTENSIVE CARE UNIT MARKET, BY OTHERS, 2024 & 2035 (USD MILLION) 107 TABLE 20 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER, 2024 & 2035 (USD MILLION) 110 TABLE 21 GLOBAL INTENSIVE CARE UNIT MARKET, BY HOSPITAL, 2024 & 2035 (USD MILLION) 112 TABLE 22 GLOBAL INTENSIVE CARE UNIT MARKET, BY SPECIALTY CLINICS, 2024 & 2035 (USD MILLION) 114 TABLE 23 GLOBAL INTENSIVE CARE UNITS MARKET, BY REGION, 2019-2035 (USD MILLION) 116 TABLE 24 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 118 TABLE 25 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 119 TABLE 26 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 120 TABLE 27 NORTH AMERICA INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 120 TABLE 28 U.S. INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 120 TABLE 29 U.S. INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 121 TABLE 30 U.S. INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 121 TABLE 31 CANADA INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 122 TABLE 32 CANADA INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 122 TABLE 33 CANADA INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 123 TABLE 34 EUROPE INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 125 TABLE 35 EUROPE: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 126 TABLE 36 EUROPE INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 126 TABLE 37 EUROPE INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 127 TABLE 38 GERMANY INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 127 TABLE 39 GERMANY INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 128 TABLE 40 GERMANY INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 128 TABLE 41 UK INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 128 TABLE 42 UK INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 129 TABLE 43 UK INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 129 TABLE 44 FRANCE INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 130 TABLE 45 FRANCE INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 130 TABLE 46 FRANCE INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 131 TABLE 47 RUSSIA INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 131 TABLE 48 RUSSIA INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 132 TABLE 49 RUSSIA INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 132 TABLE 50 ITALY INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 132 TABLE 51 ITALY INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 133 TABLE 52 ITALY INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 133 TABLE 53 SPAIN INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 134 TABLE 54 SPAIN INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 134 TABLE 55 SPAIN INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 135 TABLE 56 REST OF EUROPE INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 135 TABLE 57 REST OF EUROPE INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 136 TABLE 58 REST OF EUROPE INTENSIVE CARE UNITS MARKET, BY END USER, 2019-2035 (USD MILLION) 136 TABLE 59 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 139 TABLE 60 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 140 TABLE 61 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 140 TABLE 62 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 141 TABLE 63 CHINA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 141 TABLE 64 CHINA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 142 TABLE 65 CHINA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 142 TABLE 66 INDIA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 142 TABLE 67 INDIA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 143 TABLE 68 INDIA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 143 TABLE 69 JAPAN: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 144 TABLE 70 JAPAN: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 144 TABLE 71 JAPAN: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 144 TABLE 72 SOUTH KOREA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 145 TABLE 73 SOUTH KOREA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 146 TABLE 74 SOUTH KOREA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 146 TABLE 75 MALAYSIA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 146 TABLE 76 MALAYSIA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 147 TABLE 77 MALAYSIA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 147 TABLE 78 THAILAND: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 148 TABLE 79 THAILAND: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 148 TABLE 80 THAILAND: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 148 TABLE 81 INDONESIA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 149 TABLE 82 INDONESIA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 150 TABLE 83 INDONESIA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 150 TABLE 84 REST OF ASIA PACIFIC: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 150 TABLE 85 REST OF ASIA PACIFIC: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 151 TABLE 86 REST OF ASIA PACIFIC: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 151 TABLE 87 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 154 TABLE 88 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 154 TABLE 89 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 155 TABLE 90 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 155 TABLE 91 BRAZIL: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 156 TABLE 92 BRAZIL: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 156 TABLE 93 BRAZIL: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 157 TABLE 94 MEXICO: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 157 TABLE 95 MEXICO: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 158 TABLE 96 MEXICO: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 158 TABLE 97 ARGENTINA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 159 TABLE 98 ARGENTINA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 159 TABLE 99 ARGENTINA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 159 TABLE 100 REST OF SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 160 TABLE 101 REST OF SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 161 TABLE 102 REST OF SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY END USER,2019–2035 (USD MILLION) 161 TABLE 103 MIDDLE EAST & AFRICA: INTENSIVE CARE UNIT MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 164 TABLE 104 MEA INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 165 TABLE 105 MEA INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 165 TABLE 106 MEA INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 166 TABLE 107 GCC COUNTRIES INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 166 TABLE 108 GCC COUNTRIES INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 167 TABLE 109 GCC COUNTRIES INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 167 TABLE 110 SOUTH AFRICA INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 168 TABLE 111 SOUTH AFRICA INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 168 TABLE 112 SOUTH AFRICA INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 169 TABLE 113 REST OF MEA INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 169 TABLE 114 REST OF MEA INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 170 TABLE 115 REST OF MEA INTENSIVE CARE UNIT MARKET, BY END USER, 2019-2035 (USD MILLION) 170 TABLE 116 PRODUCT LAUNCH 177 TABLE 117 AGREEMENT AND PARTNERSHIP 177 TABLE 118 OTHER 178 TABLE 119 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 181 TABLE 120 KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENT 181 TABLE 121 MEDTRONIC: PRODUCTS OFFERED 184 TABLE 122 MEDTRONIC: KEY DEVELOPMENT 185 TABLE 123 HAMILTON MEDICAL AG: PRODUCTS OFFERED 188 TABLE 124 GETINGE AB: PRODUCTS OFFERED 191 TABLE 125 GETINGE AB: KEY DEVELOPMENT 192 TABLE 126 GE HEALTHCARE: PRODUCTS OFFERED 196 TABLE 127 STRYKER CORPORATION: PRODUCTS OFFERED 199 TABLE 128 SHENZHEN MINDRAY BIO‑MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 203 TABLE 129 VYAIRE MEDICAL, INC.: PRODUCTS OFFERED 206 TABLE 130 ICU MEDICAL, INC.: PRODUCTS OFFERED TABLE 131 ICU MEDICAL, INC.: KEY DEVELOPMENTS TABLE 132 BAXTER INTERNATIONAL: PRODUCTS OFFERED TABLE 133 BAXTER INTERNATIONAL: KEY DEVELOPMENTS LIST OF FIGURES FIGURE 1 GLOBAL INTENSIVE CARE UNIT MARKET: STRUCTURE 22 FIGURE 2 GLOBAL INTENSIVE CARE UNIT MARKET: MARKET GROWTH FACTOR ANALYSIS (2025-2035) 39 FIGURE 3 DRIVER IMPACT ANALYSIS (2025-2035) 44 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2025-2035) 47 FIGURE 5 PORTER’S FIVE FORCES MODEL: GLOBAL INTENSIVE CARE UNIT MARKET 71 FIGURE 6 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, SEGMENT ATTRACTIVENESS ANALYSIS 77 FIGURE 7 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION) 78 FIGURE 8 GLOBAL INTENSIVE CARE UNIT MARKET, BY PRODUCT TYPE, 2024 (% SHARE) 79 FIGURE 9 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS 97 FIGURE 10 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 98 FIGURE 11 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 (% SHARE) 99 FIGURE 12 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS 109 FIGURE 13 GLOBAL INTENSIVE CARE UNIT MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 109 FIGURE 14 GLOBAL INTENSIVE CARE UNIT MARKET, BY END USER, 2024 (% SHARE) 110 FIGURE 15 GLOBAL MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 115 FIGURE 16 GLOBAL INTENSIVE CARE UNIT MARKET, BY COUNTRY, 2024 (% SHARE) 116 FIGURE 17 NORTH AMERICA MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 117 FIGURE 18 NORTH AMERICA MARKET: SWOT ANALYSIS 118 FIGURE 19 NORTH AMERICA INTENSIVE CARE UNITS MARKET SHARE (%), BY COUNTRY, 2024 119 FIGURE 20 EUROPE MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 124 FIGURE 21 EUROPE MARKET: SWOT ANALYSIS 124 FIGURE 22 EUROPE INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 125 FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 138 FIGURE 24 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 138 FIGURE 25 ASIA-PACIFIC: INTENSIVE CARE UNITS MARKET SHARE, BY COUNTRY, 2024 (%) 139 FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: INTENSIVE CARE UNITS MARKET, 2019-2035 (USD MILLION) 153 FIGURE 27 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 153 FIGURE 28 SOUTH AMERICA: INTENSIVE CARE UNITS MARKET SHARE, BY COUNTRY, 2024 (%) 154 FIGURE 1 MIDDLE EAST & AFRICA MARKET: SWOT ANALYSIS 163 FIGURE 2 MIDDLE EAST & AFRICA: INTENSIVE CARE UNIT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 163 FIGURE 3 MIDDLE EAST & AFRICA: BIOSURGERY MARKET SHARE (%), BY COUNTRY, 2024 164 FIGURE 4 COMPETITOR DASHBOARD: GLOBAL UNIT DOSE PACKAGING MARKET 173 FIGURE 5 GLOBAL UNIT DOSE PACKAGING MARKET: COMPETITIVE ANALYSIS, 2024 174 FIGURE 6 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 182 FIGURE 7 MEDTRONIC: SWOT ANALYSIS 185 FIGURE 8 HAMILTON MEDICAL AG: SWOT ANALYSIS 188 FIGURE 9 GETINGE AB: SWOT ANALYSIS 192 FIGURE 10 GE HEALTHCARE: SWOT ANALYSIS 197 FIGURE 11 STRYKER CORPORATION: SWOT ANALYSIS 201 FIGURE 12 SHENZHEN MINDRAY BIO‑MEDICAL ELECTRONICS CO., LTD.: SWOT ANALYSIS 204 FIGURE 13 VYAIRE MEDICAL, INC.: SWOT ANALYSIS 206 FIGURE 14 ICU MEDICAL, INC.: SWOT ANALYSIS FIGURE 15 BAXTER INTERNATIONAL: SWOT ANALYSIS

提及公司

Koninklijke Philips N.V.Medtronic plcGetinge ABGE HealthcareShenzhen Mindray Bio-Medical Electronics Co.Ltd.Hamilton Medical AGVyaire MedicalInc.ICU MedicalInc.Baxter International Inc.Stryker Corporation

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們